» Articles » PMID: 34092823

Obsessive-Compulsive Disorder Driven by Aspects of Ritual Addiction: A Case Report and Review of Literature

Overview
Specialty Pharmacology
Date 2021 Jun 7
PMID 34092823
Authors
Affiliations
Soon will be listed here.
References
1.
Grassi G, Pallanti S, Righi L, Figee M, Mantione M, Denys D . Think twice: Impulsivity and decision making in obsessive-compulsive disorder. J Behav Addict. 2015; 4(4):263-72. PMC: 4712760. DOI: 10.1556/2006.4.2015.039. View

2.
Esalatmanesh S, Abrishami Z, Zeinoddini A, Rahiminejad F, Sadeghi M, Najarzadegan M . Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial. Psychiatry Clin Neurosci. 2016; 70(11):517-526. DOI: 10.1111/pcn.12430. View

3.
Figee M, Pattij T, Willuhn I, Luigjes J, van den Brink W, Goudriaan A . Compulsivity in obsessive-compulsive disorder and addictions. Eur Neuropsychopharmacol. 2016; 26(5):856-68. DOI: 10.1016/j.euroneuro.2015.12.003. View

4.
Pittenger C, Bloch M, Wasylink S, Billingslea E, Simpson R, Jakubovski E . Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial. J Clin Psychiatry. 2015; 76(8):1075-84. PMC: 4560666. DOI: 10.4088/JCP.14m09123. View

5.
Lafleur D, Pittenger C, Kelmendi B, Gardner T, Wasylink S, Malison R . N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology (Berl). 2005; 184(2):254-6. DOI: 10.1007/s00213-005-0246-6. View